V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 30079426 | 30090106 | null | 91.95 | Palliative (P) | 2019-06-30 | 2019-06-30 | 111 Trial (formerly BEP 111) | 02 | null | CISPLATIN + VINORELBINE | 101793962 |
| 30122561 | 30091048 | 1.74 | 79 | null | 2020-01-24 | 2020-01-24 | 111 Trial (formerly BEP 111) | 02 | N | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 100315075 |
| 30122851 | 30091057 | 1.76 | 94.1 | Curative (C) | 2020-09-26 | 2020-10-08 | 111 Trial (formerly BEP 111) | 02 | null | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 101671833 |
| 30138355 | 30091334 | 1.85 | 65 | Palliative (P) | null | 2017-05-28 | 111 Trial (formerly BEP 111) | 02 | N | IVA | 100951576 |
| 30174040 | 30091946 | 1.68 | 71 | Curative (C) | 2018-05-02 | 2018-05-09 | 111 Trial (formerly BEP 111) | 02 | null | ERLOTINIB | 101642481 |
| 80048334 | 80050052 | 1.78 | 81.4 | Adjuvant (A) | 2019-03-06 | 2019-03-06 | A-PREDICT TRIAL | N | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100969075 |
| 80043022 | 80047622 | 1.64 | 13.3 | null | 2019-02-08 | 2019-02-11 | A-PREDICT TRIAL | N | N | ENZALUTAMIDE | 101109149 |
| 70079038 | 70181751 | null | null | Curative (C) | 2019-05-11 | 2019-08-30 | A2G trial Asparaginase | 02 | N | NOT MATCHED | 101529921 |
| 70075281 | 70155977 | 1.54 | 58.5 | Neo-adjuvant (N) | 2017-10-09 | 2017-11-12 | A2G trial Asparaginase | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 101493128 |
| 70074961 | 70155874 | 1.71 | null | null | 2018-11-19 | 2018-11-22 | A2G trial Asparaginase | 02 | null | NOT MATCHED | 100030200 |
| 70073943 | 70133010 | 1.69 | 57.25 | 03 | 2019-11-12 | 2019-11-15 | A2G trial Asparaginase | 02 | N | BRENTUXIMAB | 101802289 |
| 70074809 | 70099999 | 1.4 | 55.3 | Curative (C) | 2017-12-20 | 2018-03-12 | A2G trial Asparaginase | 02 | N | NOT MATCHED | 100164790 |
| 20152813 | 20087841 | 1.73 | 84.7 | Adjuvant (A) | 2021-02-04 | 2021-02-20 | ABC-08 Trial | 02 | N | ACELARATE TRIAL | 100598057 |
| 20029260 | 20085737 | 1.58 | 53.6 | Palliative (P) | 2017-11-05 | 2017-11-07 | ABC-08 Trial | N | N | PAZOPANIB | 100332183 |
| 20055534 | 20086641 | 1.67 | 76 | Palliative (P) | 2019-03-31 | 2019-04-16 | ABC-08 Trial | 02 | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 100077497 |
| 20108852 | 20087195 | 1.82 | 96 | 03 | 2019-02-02 | 2019-03-01 | ABC-08 Trial | 02 | N | CABAZITAXEL | 100885043 |
| 40166034 | 40250111 | 1.74 | 63 | null | 2017-01-19 | 2017-02-10 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100894350 |
| 40166719 | 40281679 | 1.61 | 61.2 | null | 2019-12-24 | 2020-01-18 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100493032 |
| 40167659 | 40282038 | 1.65 | 74.9 | null | 2019-02-22 | 2019-02-23 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101226279 |
| 40169506 | 40316449 | 1.56 | 99 | null | 2020-10-06 | 2020-10-14 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101376458 |
| 40162821 | 40197265 | 1.64 | 75.8 | Palliative (P) | 2020-01-31 | 2020-03-15 | ABEMACICLIB + DENOSUMAB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101647223 |
| 70094132 | 70114368 | 1.59 | 93.8 | Curative (C) | 2019-01-19 | 2019-04-16 | ABEMACICLIB + FULVESTRANT | N | N | GEMCARBO | 101165139 |
| 90060926 | 90032790 | 1.56 | 63 | Palliative (P) | 2018-07-19 | 2018-07-20 | ABEMACICLIB + FULVESTRANT | 02 | N | BEVACIZUMAB | 101184472 |
| 70084197 | 70114238 | 1.55 | 40 | Palliative (P) | 2018-07-20 | 2018-08-08 | ABEMACICLIB + FULVESTRANT | 02 | N | VINDESINE | 101410772 |
| 70089584 | 70114303 | 1.53 | 67 | null | null | 2016-08-15 | ABEMACICLIB + FULVESTRANT | 02 | N | TALIMOGENE LAHERPAREPVEC | 101192065 |
| 40162047 | 40196812 | 1.71 | 95.8 | Palliative (P) | 2020-12-29 | 2021-01-12 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101389353 |
| 10425011 | 10041454 | 0 | 81.25 | Palliative (P) | 2018-11-28 | 2018-12-04 | ABEMACICLIB + FULVESTRANT | 02 | N | AML17 TRIAL | 100617632 |
| 10447690 | 10041978 | 1.75 | 95.7 | Palliative (P) | 2019-06-23 | 2019-06-28 | ABEMACICLIB + FULVESTRANT | 02 | N | MYELOMA XII TRIAL | 100413450 |
| 10028896 | 10042589 | 1.82 | 112.4 | null | 2017-12-17 | 2018-01-12 | ABEMACICLIB + FULVESTRANT | 02 | null | THALIDOMIDE | 101710164 |
| 10401421 | 10056997 | 1.73 | 58.4 | Palliative (P) | 2019-05-04 | 2019-05-04 | ABEMACICLIB + FULVESTRANT | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101610417 |
| 10407064 | 10057045 | 1.66 | 72.2 | null | null | 2019-11-26 | ABEMACICLIB + FULVESTRANT | 02 | null | ERIBULIN | 100531099 |
| 10433229 | 10057383 | null | 72.2 | Adjuvant (A) | 2018-04-11 | 2018-04-26 | ABEMACICLIB + FULVESTRANT | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100198833 |
| 10454792 | 10057606 | 1.84 | 83.35 | Palliative (P) | 2018-07-29 | 2018-08-01 | ABEMACICLIB + FULVESTRANT | 2 | N | BENDAMUSTINE + OBINUTUZUMAB | 101314395 |
| 10466700 | 10057725 | 1.62 | 70.8 | null | 2018-11-15 | 2018-11-15 | ABEMACICLIB + FULVESTRANT | 02 | null | OBINUTUZUMAB | 101345294 |
| 10299345 | 10065542 | 0 | 50.8 | null | 2022-01-28 | 2022-03-07 | ABEMACICLIB + FULVESTRANT | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100047422 |
| 20169683 | 20134544 | 1.8 | 44.8 | null | 2017-12-12 | 2017-12-12 | ABEMACICLIB + FULVESTRANT | 02 | null | BORTEZOMIB + THALIDOMIDE | 100250789 |
| 20183907 | 20134620 | 1.77 | 88 | Palliative (P) | null | 2019-12-19 | ABEMACICLIB + FULVESTRANT | 01 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 101672692 |
| 40026177 | 40122168 | null | 106 | Adjuvant (A) | null | 2018-01-15 | ABEMACICLIB + FULVESTRANT | 99 | N | ABEMACICLIB + FULVESTRANT | 101076072 |
| 40001373 | 40121611 | 0.65 | 63.9 | null | 2021-06-25 | 2021-07-12 | ABEMACICLIB + FULVESTRANT | 02 | N | ABEMACICLIB + FULVESTRANT | 101495115 |
| 20218158 | 20170059 | 1.61 | 59 | Palliative (P) | 2020-11-21 | 2020-12-02 | ABEMACICLIB + FULVESTRANT | 02 | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100994352 |
| 40162084 | 40196833 | 1.69 | 82.2 | null | 2021-03-30 | 2021-04-12 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100816085 |
| 40162051 | 40196814 | 0 | 72.4 | null | 2021-04-08 | 2021-05-03 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 101537605 |
| 40162022 | 40196795 | 1.64 | 59.4 | null | 2022-04-08 | 2022-04-24 | ABEMACICLIB + FULVESTRANT | 02 | null | ABEMACICLIB + FULVESTRANT | 100655171 |
| 70074840 | 70143474 | 1.58 | 69.5 | Curative (C) | null | 2020-10-11 | ABEMACICLIB + FULVESTRANT | N | N | DURVALUMAB | 101779036 |
| 70086175 | 70143627 | 0.81 | 72.5 | Curative (C) | 2018-02-18 | 2019-04-21 | ABEMACICLIB + FULVESTRANT | 02 | null | IDARUBICIN + IMATINIB + VINCRISTINE | 100596799 |
| 70073308 | 70163053 | 1.76 | 110.4 | null | 2020-06-23 | 2020-07-06 | ABEMACICLIB + FULVESTRANT | 02 | N | IRINOTECAN + MDG | 100139185 |
| 70081954 | 70163144 | 1.4 | 69.2 | Curative (C) | 2016-02-17 | 2016-05-16 | ABEMACICLIB + FULVESTRANT | 02 | null | ALL RELAPSE: CYCLOPHOSPHAMIDE + CYTARABINE + NAVITOCLAX + VENETOCLAX | 101355564 |
| 70079498 | 70176224 | null | 59.6 | Curative (C) | 2019-06-20 | 2019-07-19 | ABEMACICLIB + FULVESTRANT | 02 | null | ALL INT GUIDE B INT MAINT | 101052931 |
| 90066928 | 90031078 | 0 | 63.8 | Palliative (P) | 2016-10-29 | 2016-11-23 | ABEMACICLIB + FULVESTRANT | N | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101296726 |
| 70079696 | 70114151 | 1.82 | 69.8 | Curative (C) | 2021-03-07 | 2021-03-11 | ABEMACICLIB + FULVESTRANT | 02 | N | METHOTREXATE HD + VINCRISTINE | 101464240 |